News | Radiation Therapy | May 30, 2023

RaySearch Laboratories AB announced that Yonsei Cancer Center in South Korea has treated its first patient using RayStation and RayCare for carbon ion radiation therapy 

RaySearch Laboraties AB (publ) announces that Yonsei Cancer Center in South Korea has treated its first patient using RayStation and RayCare for carbon ion radiation therapy

May 30, 2023 — The first treatment, for a patient with prostate cancer, was successfully carried out on April 28. Yonsei Cancer Center uses the RayStation treatment planning system for photon and carbon ion treatment planning and was the first clinic in the Asia-Pacific region to adopt the RayCareoncology information system. Now, the center becomes the first clinic in this region to start clinical operations with RayCare. At Yonsei, RayCare is connected to the Toshiba carbon ion accelerator facility equppiped with two superconducting carbon gantry rooms and one fixed beam line room. 

Ik Jae Lee, Director, Yonsei Cancer Center, says: “We are proud to have treated our first patient using RayStation and RayCare. Yonsei was the first carbon-ion therapy center in Korea. We provide our patients with innovative carbon-ion therapy with the most advanced systems for radiation therapy planning and oncology information. We firmly believe that the support and cutting-edge techniques of RaySearch play extremely important roles in making this a reality at Yonsei and in Korea.” 

Johan Löf, founder and CEO, RaySearch, says: “We are pleased that Yonsei has started clinical treatments with carbon ion therapy using RayStation and RayCare. RaySearch is proud to take part in the field of carbon ion therapy as a leading supplier. We are also pleased to see that our RayCare oncology information system with Yonsei now is in clinical use in Asia.” 

For more information: www.raysearchlabs.com


Related Content

News | Radiation Therapy

Feb. 4, 2026 — On World Cancer Day (02.04.26), the American Society for Radiation Oncology (ASTRO) and the European ...

Time February 04, 2026
arrow
News | Radiology Imaging

Feb. 4, 2026 — The Royal College of Radiologists (RCR) has issued its initial reaction to the British government's ...

Time February 04, 2026
arrow
News | Radiopharmaceuticals and Tracers

Jan. 29, 2026 — The American Society for Radiation Oncology (ASTRO) has launched a national program creating Authorized ...

Time January 30, 2026
arrow
News | Radiation Oncology

Jan. 27, 2026 — Researchers at the Icahn School of Medicine at Mount Sinai, in collaboration with other leading ...

Time January 29, 2026
arrow
News | Radiology Imaging

Jan. 21, 2026 — Cathpax, a spin-off of the Lemer Pax group that designs, develops and commercializes team-wide, full ...

Time January 22, 2026
arrow
News | Radiation Therapy

Jan. 16, 2026 — Elekta has announced that its Elekta Evo* CT-Linac has received 510(k) clearance from the U.S. Food and ...

Time January 16, 2026
arrow
News | Radiopharmaceuticals and Tracers

Dec. 11, 2025 — Telix Pharmaceuticals Ltd. has announced a strategic clinical collaboration with Varian, a Siemens ...

Time December 11, 2025
arrow
News | FDA

Dec. 02, 2025 — Alpha Tau Medical Ltd., the developer of the alpha-radiation cancer therapy Alpha DaRT, has announced ...

Time December 04, 2025
arrow
News | Interventional Radiology

Nov. 12, 2025 — On Nov. 11, Huntsman Cancer Institute at the University of Utah (the U) opened its first specialized ...

Time November 13, 2025
arrow
News | Radiology Business

Nov. 12, 2025 — Siemens has announced plans to deconsolidate its remaining stake in Siemens Healthineers (currently ...

Time November 13, 2025
arrow
Subscribe Now